Companies To Watch

  1. Companies To Watch: Madrigal Pharmaceuticals 10/10/2017

    Madrigal Pharmaceuticals is taking on NASH and other liver diseases by targeting the thyroid hormone beta receptor. The company expects to begin seeing top line Phase 2 trial results in late 2017, with more released in 2018.

  2. Companies To Watch: Arena Pharmaceuticals 9/8/2017

    By early 2016, Arena’s board decided to remake the company, beginning with new management and a new strategy. Since then, the company has evolved back to a core drug development platform.

  3. Companies To Watch: ProMIS Neurosciences 8/9/2017

    ProMIS Neurosciences believes inaccurate targeting of mAbs is to blame, in fact, for lack of progress against Alzheimer’s disease.

  4. Companies To Watch: GeNeuro 7/7/2017

    Outside skepticism about GeNeuro’s scientific concept has made fund-raising even harder than usual for a startup. But the Swiss company has found considerable support in Europe.